Dreyer Scott bought COLL
August 18, 2025 · Form 4 insider transaction
Dreyer Scott bought 16,389 shares of Collegium Pharmaceutical, Inc. at $21.34 per share, a transaction worth $349.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,389
Price
$21.34
Total value
$349.7K
InsiderDreyer Scott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2025
Filing dateAugust 20, 2025
Shares owned after120,002
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.